Meet Dr. Demetre Daskalakis, Biden’s New Weapon Against HIV

If Dr. Demetre Daskalakis is harboring anxieties over taking a new national health position in the middle of two global pandemics, it doesn’t show.

Formerly the deputy commissioner for the Division of Disease Control at the New York City Department of Health and Mental Hygiene, Daskalakis was hired as director of the Division of HIV/AIDS Prevention at the Centers for Disease Control and Prevention late last year. His first weeks on the job coincided with a frightening transition of presidential leadership, an insurrection at the U.S. Capitol, and devastating numbers of COVID deaths in the nation – typically between 2,000 and 4,000 fatalities a day.

But Daskalakis, one of the most visible government officials overseeing HIV policy, does not sound panicked or overwhelmed in a recent conversation with Plus.

“It’s a great time to land,” Daskalakis says. “We’re at a crossroads of strategy and implementation. Leading CDC’s Division of HIV/AIDS Prevention is my dream job. I believe that everything I’ve done in my career has been leading me to this role.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below